ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 331121 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 331121; 2) Community: the network communities that were significantly associated with the response to NSC 331121; 3) Molecule: the relationships between components within communities and NSC 331121; 4) MDR: the compounds that were significantly associated with the NSC 331121.

NSC Compound Enrichment Correlation
NSC 645809 Null 0.00174331675630443 0.22560137
NSC 650351 Null 0.00174331675630443 0.5857278
NSC 667874 Null 0.00174331675630443 0.35964337
NSC 675967 Null 0.00174331675630443 0.38455506
NSC 682825 Propanimidoyl chloride, N-[[[(4-bromophenyl)amino] carbonyl]oxy]-2-methyl- 0.00174331675630443 0.70368052
NSC 684496 Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester 0.00174331675630443 0.69801719
NSC 714379 Null 0.00174331675630443 0.44178304
NSC 71669 Null 0.00174331675630443 0.14418428
NSC 740 Methotrexate 0.00174331675630443 0.27179667
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.00174331675630443 0.23096666
Total:131  Current:14    [First] [Prev] [Next] [Last]